Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I Early Feasibility Study to Evaluate the Initial Safety and Device Functionality of VectRx Thermal Therapy Added to Chemotherapy Treatment of Pancreatic Tumors

Summary

The purpose of this phase 1 trial is to determine the safety and feasibility of VectRx along with standard of care chemotherapy in patients with pancreatic ductal adenocarcinoma (PDAC).

General Information

NCT#: NCT05959395
Study ID: GCC 20122
Trial Phase: Phase I

Trial Sponsor: NeoTherma Oncology
Therapies Used in This Trial: Fluorouracil, Gemcitabine, VectRx Thermal Therapy

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search